Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A John Petkau

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurology|November 12, 2003
Statistical approaches to assessing the effects of neutralizing antibodies: IFNbeta-1b in the pivotal trial of relapsing-remitting multiple sclerosisA John Petkau, Rick White
Statistics in Medicine|May 24, 2005
Application of hidden Markov models to multiple sclerosis lesion count dataRachel MacKay Altman, A John Petkau
Neurology|November 16, 2007
Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosisYinshan Zhao, Anthony Traboulsee, A John Petkau, et al.
Menopause (New York, N.Y.)|June 12, 2010
Role of androgens in women's sexual dysfunctionRosemary Basson, Lori A Brotto, A John Petkau, et al.
The Journal of Sexual Medicine|December 15, 2010
Predictors of sexual desire disorders in womenLori A Brotto, A John Petkau, Fernand Labrie, et al.
Statistics in Medicine|October 4, 2011
A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patientsRachel MacKay Altman, A John Petkau, Dean Vrecko, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trialsYinshan Zhao, Yumi Kondo, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trialsJing Dong, Yinshan Zhao, A John Petkau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosisA John Petkau, Richard A White, George C Ebers, et al.
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurology|November 12, 2003
Statistical approaches to assessing the effects of neutralizing antibodies: IFNbeta-1b in the pivotal trial of relapsing-remitting multiple sclerosisA John Petkau, Rick White
Statistics in Medicine|May 24, 2005
Application of hidden Markov models to multiple sclerosis lesion count dataRachel MacKay Altman, A John Petkau
Neurology|November 16, 2007
Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosisYinshan Zhao, Anthony Traboulsee, A John Petkau, et al.
Menopause (New York, N.Y.)|June 12, 2010
Role of androgens in women's sexual dysfunctionRosemary Basson, Lori A Brotto, A John Petkau, et al.
The Journal of Sexual Medicine|December 15, 2010
Predictors of sexual desire disorders in womenLori A Brotto, A John Petkau, Fernand Labrie, et al.
Statistics in Medicine|October 4, 2011
A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patientsRachel MacKay Altman, A John Petkau, Dean Vrecko, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trialsYinshan Zhao, Yumi Kondo, Anthony Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trialsJing Dong, Yinshan Zhao, A John Petkau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosisA John Petkau, Richard A White, George C Ebers, et al.
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Pageof 1